Login to Your Account



Altheos Boosts Series A by $12.5M for Glaucoma Trial

By Catherine Shaffer
Staff Writer

Friday, February 10, 2012
Altheos Inc., of South San Francisco, raised an additional $12.5 million in its Series A financing and will be cashing the check immediately to support a Phase IIa trial of its glaucoma candidate, which recently dosed its first patient.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription